
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation
Rubina Tuladhar, Yunku Yeu, John T. Piazza, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 196
Rubina Tuladhar, Yunku Yeu, John T. Piazza, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 196
Showing 1-25 of 196 citing articles:
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski, Laurent C. Francioli, Grace Tiao, et al.
Nature (2020) Vol. 581, Iss. 7809, pp. 434-443
Open Access | Times Cited: 8031
Konrad J. Karczewski, Laurent C. Francioli, Grace Tiao, et al.
Nature (2020) Vol. 581, Iss. 7809, pp. 434-443
Open Access | Times Cited: 8031
A simple and effective F0 knockout method for rapid screening of behaviour and other complex phenotypes
François Kroll, Gareth T. Powell, Marcus Ghosh, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 234
François Kroll, Gareth T. Powell, Marcus Ghosh, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 234
To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases
Fran Supek, Ben Lehner, Rik G.H. Lindeboom
Trends in Genetics (2020) Vol. 37, Iss. 7, pp. 657-668
Open Access | Times Cited: 174
Fran Supek, Ben Lehner, Rik G.H. Lindeboom
Trends in Genetics (2020) Vol. 37, Iss. 7, pp. 657-668
Open Access | Times Cited: 174
A compact Cascade–Cas3 system for targeted genome engineering
Bálint Csörgő, Lina M. León, Ilea J. Chau-Ly, et al.
Nature Methods (2020) Vol. 17, Iss. 12, pp. 1183-1190
Open Access | Times Cited: 151
Bálint Csörgő, Lina M. León, Ilea J. Chau-Ly, et al.
Nature Methods (2020) Vol. 17, Iss. 12, pp. 1183-1190
Open Access | Times Cited: 151
CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
Delilah Hendriks, Hans Clevers, Benedetta Artegiani
Cell stem cell (2020) Vol. 27, Iss. 5, pp. 705-731
Open Access | Times Cited: 140
Delilah Hendriks, Hans Clevers, Benedetta Artegiani
Cell stem cell (2020) Vol. 27, Iss. 5, pp. 705-731
Open Access | Times Cited: 140
KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection
Eric Fagerberg, John Attanasio, Christine Dien, et al.
Science (2025) Vol. 387, Iss. 6735
Closed Access | Times Cited: 2
Eric Fagerberg, John Attanasio, Christine Dien, et al.
Science (2025) Vol. 387, Iss. 6735
Closed Access | Times Cited: 2
Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles
Georg Michlits, Julian Jude, Matthias Hinterndorfer, et al.
Nature Methods (2020) Vol. 17, Iss. 7, pp. 708-716
Closed Access | Times Cited: 113
Georg Michlits, Julian Jude, Matthias Hinterndorfer, et al.
Nature Methods (2020) Vol. 17, Iss. 7, pp. 708-716
Closed Access | Times Cited: 113
Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
Mike Broeders, Pablo Herrero-Hernandez, Martijn P. T. Ernst, et al.
iScience (2019) Vol. 23, Iss. 1, pp. 100789-100789
Open Access | Times Cited: 92
Mike Broeders, Pablo Herrero-Hernandez, Martijn P. T. Ernst, et al.
iScience (2019) Vol. 23, Iss. 1, pp. 100789-100789
Open Access | Times Cited: 92
Efficient combinatorial targeting of RNA transcripts in single cells with Cas13 RNA Perturb-seq
Hans‐Hermann Wessels, Alejandro Méndez‐Mancilla, Yuhan Hao, et al.
Nature Methods (2022) Vol. 20, Iss. 1, pp. 86-94
Open Access | Times Cited: 50
Hans‐Hermann Wessels, Alejandro Méndez‐Mancilla, Yuhan Hao, et al.
Nature Methods (2022) Vol. 20, Iss. 1, pp. 86-94
Open Access | Times Cited: 50
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
Christopher A. Chamberlain, Eric Bennett, Anders H. Kverneland, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 417-428
Open Access | Times Cited: 41
Christopher A. Chamberlain, Eric Bennett, Anders H. Kverneland, et al.
Molecular Therapy — Oncolytics (2022) Vol. 24, pp. 417-428
Open Access | Times Cited: 41
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application
Yuko Kitano, Sayaka Nishimura, Tomoaki Kato, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 26, pp. 15-25
Open Access | Times Cited: 41
Yuko Kitano, Sayaka Nishimura, Tomoaki Kato, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 26, pp. 15-25
Open Access | Times Cited: 41
Identification of secretory autophagy as a mechanism modulating activity-induced synaptic remodeling
Yen-Ching Chang, Yuan Gao, Joo Yeun Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 16
Open Access | Times Cited: 15
Yen-Ching Chang, Yuan Gao, Joo Yeun Lee, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 16
Open Access | Times Cited: 15
A line attractor encoding a persistent internal state requires neuropeptide signaling
George Mountoufaris, Aditya Nair, Bin Yang, et al.
Cell (2024) Vol. 187, Iss. 21, pp. 5998-6015.e18
Open Access | Times Cited: 9
George Mountoufaris, Aditya Nair, Bin Yang, et al.
Cell (2024) Vol. 187, Iss. 21, pp. 5998-6015.e18
Open Access | Times Cited: 9
Next-Generation CRISPR Technologies and Their Applications in Gene and Cell Therapy
M. Alejandra Zeballos C., Thomas Gaj
Trends in biotechnology (2020) Vol. 39, Iss. 7, pp. 692-705
Open Access | Times Cited: 70
M. Alejandra Zeballos C., Thomas Gaj
Trends in biotechnology (2020) Vol. 39, Iss. 7, pp. 692-705
Open Access | Times Cited: 70
Sport and exercise genomics: the FIMS 2019 consensus statement update
Kumpei Tanisawa, Guan Wang, Jane T. Seto, et al.
British Journal of Sports Medicine (2020) Vol. 54, Iss. 16, pp. 969-975
Open Access | Times Cited: 66
Kumpei Tanisawa, Guan Wang, Jane T. Seto, et al.
British Journal of Sports Medicine (2020) Vol. 54, Iss. 16, pp. 969-975
Open Access | Times Cited: 66
Broadening the GMO risk assessment in the EU for genome editing technologies in agriculture
Katharina Kawall, Janet Cotter, Christoph Then
Environmental Sciences Europe (2020) Vol. 32, Iss. 1
Open Access | Times Cited: 62
Katharina Kawall, Janet Cotter, Christoph Then
Environmental Sciences Europe (2020) Vol. 32, Iss. 1
Open Access | Times Cited: 62
A functional genetic toolbox for human tissue-derived organoids
Dawei Sun, Lewis Evans, Francesca Perrone, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 51
Dawei Sun, Lewis Evans, Francesca Perrone, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 51
Genome editing in mammalian cells using the CRISPR type I-D nuclease
Keishi Osakabe, Naoki Wada, Emi Murakami, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 11, pp. 6347-6363
Open Access | Times Cited: 45
Keishi Osakabe, Naoki Wada, Emi Murakami, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 11, pp. 6347-6363
Open Access | Times Cited: 45
Optimized CRISPR-mediated gene knockin reveals FOXP3-independent maintenance of human Treg identity
Avery J. Lam, David Lin, Jana Gillies, et al.
Cell Reports (2021) Vol. 36, Iss. 5, pp. 109494-109494
Open Access | Times Cited: 43
Avery J. Lam, David Lin, Jana Gillies, et al.
Cell Reports (2021) Vol. 36, Iss. 5, pp. 109494-109494
Open Access | Times Cited: 43
CRISPR nuclease off-target activity and mitigation strategies
Beeke Wienert, M. Kyle Cromer
Frontiers in Genome Editing (2022) Vol. 4
Open Access | Times Cited: 37
Beeke Wienert, M. Kyle Cromer
Frontiers in Genome Editing (2022) Vol. 4
Open Access | Times Cited: 37
Precise CRISPR-Cas–mediated gene repair with minimal off-target and unintended on-target mutations in human hematopoietic stem cells
Ngoc Tung Tran, Eric Danner, Xun Li, et al.
Science Advances (2022) Vol. 8, Iss. 22
Open Access | Times Cited: 31
Ngoc Tung Tran, Eric Danner, Xun Li, et al.
Science Advances (2022) Vol. 8, Iss. 22
Open Access | Times Cited: 31
CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
Evangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 450-461
Open Access | Times Cited: 30
Evangelos Konstantinidis, Agnieszka Molisak, Florian Perrin, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 450-461
Open Access | Times Cited: 30
Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry
Michael J. Ellis, Christiana Lekka, Katie Holden, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 8
Michael J. Ellis, Christiana Lekka, Katie Holden, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 8
Efficient CRISPR/Cas9‐based plant genomic fragment deletions by microhomology‐mediated end joining
Jiantao Tan, Yanchang Zhao, Bin Wang, et al.
Plant Biotechnology Journal (2020) Vol. 18, Iss. 11, pp. 2161-2163
Open Access | Times Cited: 45
Jiantao Tan, Yanchang Zhao, Bin Wang, et al.
Plant Biotechnology Journal (2020) Vol. 18, Iss. 11, pp. 2161-2163
Open Access | Times Cited: 45
CASC3 promotes transcriptome-wide activation of nonsense-mediated decay by the exon junction complex
Jennifer V. Gerbracht, Volker Boehm, Thiago Britto‐Borges, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 15, pp. 8626-8644
Open Access | Times Cited: 44
Jennifer V. Gerbracht, Volker Boehm, Thiago Britto‐Borges, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 15, pp. 8626-8644
Open Access | Times Cited: 44